E. Ohman J:or Asset Management’s Idexx Laboratories IDXX Stock Holding History

E. Ohman J:or Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.06M	Buy	3,911 +390	+11%	+$219K	0.05%	198
2026 Q1	$1.98M	Hold	3,521	–	–	0.05%	185
2025 Q4	$2.38M	Sell	3,521 -29	-0.8%	-$19.8K	0.06%	160
2025 Q3	$2.27M	Buy	3,550 +300	+9%	+$182K	0.05%	172
2025 Q2	$1.74M	Sell	3,250 -500	-13%	-$239K	0.04%	195
2025 Q1	$1.57M	Hold	3,750	–	–	0.04%	203
2024 Q4	$1.55M	Buy	3,750 +450	+14%	+$197K	0.04%	213
2024 Q3	$1.67M	Sell	3,300 -310	-9%	-$151K	0.04%	181
2024 Q2	$1.76M	Buy	3,610 +310	+9%	+$156K	0.04%	171
2024 Q1	$1.78M	Hold	3,300	–	–	0.05%	172
2023 Q4	$1.83M	Sell	3,300 -500	-13%	-$235K	0.07%	138
2023 Q3	$1.66M	Hold	3,800	–	–	0.06%	167
2023 Q2	$1.91M	Hold	3,800	–	–	0.07%	155
2023 Q1	$1.9M	Buy	3,800 +300	+9%	+$144K	0.07%	155
2022 Q4	$1.43M	Hold	3,500	–	–	0.06%	193
2022 Q3	$1.14M	Hold	3,500	–	–	0.05%	212
2022 Q2	$1.23M	Sell	3,500 -100	-3%	-$40.8K	0.05%	206
2022 Q1	$1.97M	Sell	3,600 -400	-10%	-$210K	0.07%	175
2021 Q4	$2.63M	Buy	4,000 +300	+8%	+$188K	0.08%	156
2021 Q3	$2.3M	Sell	3,700 -300	-8%	-$202K	0.07%	156
2021 Q2	$2.53M	Buy	4,000 +700	+21%	+$387K	0.08%	153
2021 Q1	$1.61M	Buy	3,300 +1,600	+94%	+$802K	0.06%	188
2020 Q4	$850K	Sell	1,700 -300	-15%	-$134K	0.03%	249
2020 Q3	$786K	Hold	2,000	–	–	0.04%	210
2020 Q2	$660K	Hold	2,000	–	–	0.04%	218
2020 Q1	$484K	Buy	+2,000	New	+$522K	0.04%	209
2019 Q4	–	Sell	-4,000	Closed	-$1.09M	–	450
2019 Q3	$1.09M	Buy	4,000 +600	+18%	+$167K	0.07%	154
2019 Q2	$936K	Hold	3,400	–	–	0.06%	165
2019 Q1	$760K	Sell	3,400 -600	-15%	-$124K	0.05%	186
2018 Q4	$744K	Hold	4,000	–	–	0.05%	176
2018 Q3	$999K	Buy	4,000 +600	+18%	+$146K	0.06%	172
2018 Q2	$741K	Buy	3,400 +700	+26%	+$144K	0.05%	192
2018 Q1	$517K	Buy	2,700 +300	+13%	+$55.4K	0.04%	243
2017 Q4	$375K	Buy	2,400 +400	+20%	+$63K	0.03%	330
2017 Q3	$311K	Hold	2,000	–	–	0.03%	345
2017 Q2	$323K	Sell	2,000 -700	-26%	-$114K	0.03%	333
2017 Q1	$417K	Buy	2,700 +1,000	+59%	+$138K	0.05%	279
2016 Q4	$199K	Hold	1,700	–	–	0.03%	409
2016 Q3	$192K	Hold	1,700	–	–	0.03%	396
2016 Q2	$158K	Buy	+1,700	New	+$146K	0.03%	397

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

E. Ohman J:or Asset Management's IDXX Position: Q2 2026 in Review

E. Ohman J:or Asset Management increased its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, buying an estimated $219K and bringing the position to 3,911 shares worth $2.06M. The position accounts for 0.05% of the portfolio, ranked #198.

E. Ohman J:or Asset Management first reported a position in IDXX in Q2 2016 and has held it in 40 quarters since. The position peaked at $2.63M in Q4 2021. 773 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

E. Ohman J:or Asset Management held 3,911 shares of Idexx Laboratories worth $2.06M as of Q2 2026.
E. Ohman J:or Asset Management bought 390 Idexx Laboratories shares in Q2 2026, an estimated $219K.
Idexx Laboratories made up 0.05% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #198 holding.
E. Ohman J:or Asset Management first reported a position in Idexx Laboratories in Q2 2016 and has held it in 40 quarters since.
E. Ohman J:or Asset Management's Idexx Laboratories position peaked at $2.63M in Q4 2021.
773 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.